Table 2.
Estimates of the use of psychotropic drugs in 2009, 2015 and the difference between those years
| Use in 2009 (%) | Use in 2015 (%) | Difference between 2009 and 2015 and respective 95%CI (%)a | |
|---|---|---|---|
| Any psychotropic drug | |||
| Population | 20.9 | 28.2 | 6.74 (3.89–9.60)b |
| Gender | |||
| Men | 11.5 | 19.1 | 7.97 (4.23–11.71)b |
| Women | 30.9 | 37.2 | 5.54 (1.25–9.84)b |
| Age | |||
| 18–49 at baseline | 15.3 | 25.7 | 9.85 (5.90–13.79)b |
| ≥ 50 at baseline | 29.8 | 32.0 | 2.21(−1.76–6.18) |
| Antidepressants | |||
| Population | 8.3 | 11.0 | 2.80 (0.65–4.95)b |
| Gender | |||
| Men | 3.6 | 5.4 | 1.81 (−0.53–4.17) |
| Women | 12.9 | 16.6 | 3.75 (0.18–7.33)b |
| Age | |||
| 18–49 at baseline | 7.9 | 12.5 | 4.72 (1.81–7.62)b |
| ≥ 50 at baseline | 9.1 | 8.9 | 0.28 (−3.40–2.84) |
| Anxiolytics | |||
| Population | 12.3 | 14.5 | 2.36 (−0.32–5.04) |
| Gender | |||
| Men | 7.8 | 11.4 | 3.41 (−0.05–6.87) |
| Women | 16.9 | 17.7 | 1.33 (−2.75–5.42) |
| Age | |||
| 18–49 at baseline | 8.9 | 13.4 | 4.73 (1.21–8.24)b |
| ≥ 50 at baseline | 17.4 | 16.3 | 1.11 (−5.24–3.03) |
| Hypnotics/sedatives | |||
| Population | 11.4 | 16.9 | 4.81 (2.30–7.31)b |
| Gender | |||
| Men | 5.4 | 12.6 | 7.30 (3.96–10.62) b |
| Women | 17.6 | 21.1 | 2.21(−1.51–5.92) |
| Age | |||
| 18–49 at baseline | 7.0 | 13.8 | 5.84 (2.72–8.95)b |
| ≥ 50 at baseline | 18.2 | 21.5 | 3.31 (−0.86–7.47) |
a McNemar’s test
% weighted
bStatistical significance considered when 95%CI does not contain 0
CI Confidence interval